---
title: "A D S Diagnostic Ltd (523031) — Share Price, Financials & Analysis"
symbol: "523031"
company: "A D S Diagnostic Ltd"
canonical: "https://tapetide.com/stocks/523031"
bse_code: "523031"
sector: "Healthcare"
industry: "Healthcare Services"
generated_at: "2026-09-13T20:37:51.682Z"
---

# A D S Diagnostic Ltd (523031)

Canonical page: https://tapetide.com/stocks/523031

## Company

- **BSE Code:** 523031
- **Sector:** Healthcare
- **Industry:** Healthcare Services
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2006-04-17
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** adsdiagnosticltd.com

## About

ADS Diagnostic supplies and trades medical equipment. The Company offers patient monitoring systems and ultrasound machines.

## Latest Price

- **Price:** ₹11.34
- **Change:** +0.54 (+5%)
- **Open:** ₹11.34
- **Day High:** ₹11.34
- **Day Low:** ₹11.34
- **Previous Close:** ₹10.8
- **Volume:** 100
- **As Of:** 2020-05-22T01:08:25+00:00

## Key Insights

### Strengths

- Stock is trading at 0.33 times its book value
- Stock is providing a good dividend yield of 8.82%.
- Company has been maintaining a healthy dividend payout of 17.4%
- Debtor days have improved from 80.2 to 63.7 days.
- Company's working capital requirements have reduced from 76.9 days to 61.1 days

### Weaknesses

- Company's cost of borrowing seems high

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 9% | 2% | 26% |
| revenue growth | 69% | 29% | 25% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 7.72 | 7.12 | 5.95 | 4.2 | 5.96 | 2.6 | 3.37 | 4.4 | 14.59 | 5.46 | 4.04 | 3.51 |
| Expenses | 6.13 | 6.32 | 5.26 | 4.03 | 5.18 | 2.23 | 3.16 | 4.05 | 13.57 | 5 | 3.76 | 3.36 |
| Operating Profit | 1.59 | 0.8 | 0.69 | 0.17 | 0.78 | 0.37 | 0.21 | 0.35 | 1.02 | 0.46 | 0.28 | 0.15 |
| OPM % | 20.6 | 11.24 | 11.6 | 4.05 | 13.09 | 14.23 | 6.23 | 7.95 | 6.99 | 8.42 | 6.93 | 4.27 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0.19 | 0.16 | 0.16 | 0.04 | 0.12 | 0.08 | 0.06 | 0.12 | 0.18 | 0.18 | 0.13 | 0.1 |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | -0.02 | 0.01 |
| Profit before tax | 1.36 | 0.6 | 0.49 | 0.09 | 0.62 | 0.25 | 0.12 | 0.2 | 0.81 | 0.26 | 0.17 | 0.04 |
| Tax % | 22.06 | 30 | 34.69 | 22.22 | 24.19 | 24 | 41.67 | 25 | 25.93 | 23.08 | 35.29 | 25 |
| Net Profit | 1.06 | 0.42 | 0.33 | 0.07 | 0.47 | 0.19 | 0.07 | 0.15 | 0.61 | 0.2 | 0.12 | 0.03 |
| EPS in Rs | 4.83 | 1.92 | 1.5 | 0.32 | 2.14 | 0.87 | 0.32 | 0.68 | 2.78 | 0.91 | 0.55 | 0.14 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 6.38 | 8.95 | 13.52 | 9.43 | 10.1 | 13.29 | 23.96 | 16 | 28.49 | 27.6 |
| Expenses | 5.65 | 7.41 | 12.96 | 9.33 | 9.11 | 11.79 | 20.83 | 14.6 | 26.38 | 25.69 |
| Operating Profit | 0.73 | 1.54 | 0.56 | 0.1 | 0.99 | 1.5 | 3.13 | 1.4 | 2.11 | 1.91 |
| OPM % | 11.44 | 17.21 | 4.14 | 1.06 | 9.8 | 11.29 | 13.06 | 8.75 | 7.41 | 6.92 |
| Other Income | 0.29 | 0.18 | 0.81 | 1.19 | 0.36 | -0.38 | 0.1 | 0.13 | 0 | 0 |
| Interest | 0.51 | 0.45 | 0.48 | 0.56 | 0.51 | 0.44 | 0.57 | 0.3 | 0.61 | 0.59 |
| Depreciation | 0.15 | 0.16 | 0.27 | 0.29 | 0.28 | 0.19 | 0.16 | 0.15 | 0.06 | 0.04 |
| Profit before tax | 0.36 | 1.11 | 0.62 | 0.44 | 0.56 | 0.49 | 2.5 | 1.08 | 1.44 | 1.28 |
| Tax % | 41.67 | 22.52 | 24.19 | 25 | 23.21 | 16.33 | 26 | 25.93 | 26.39 | — |
| Net Profit | 0.21 | 0.85 | 0.47 | 0.34 | 0.44 | 0.41 | 1.85 | 0.81 | 1.07 | 0.96 |
| EPS in Rs | 0.96 | 3.88 | 2.14 | 1.55 | 2.01 | 1.87 | 8.44 | 3.69 | 4.88 | 4.38 |
| Dividend Payout % | 0 | 23.82 | 0 | 0 | 40.91 | 0 | 0 | 27.78 | 24.56 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 |
| Reserves | -0.31 | -0.1 | 0.77 | 1.07 | 1.41 | 1.85 | 2.13 | 3.77 | 4.34 | 5.2 |
| Borrowings | 4.19 | 3.79 | 1.81 | 5.51 | 5.29 | 3.99 | 2.54 | 2.08 | 2.31 | 3.1 |
| Other Liabilities | 2.35 | 4.18 | 11.93 | 8.54 | 5.63 | 3.92 | 5.05 | 7.83 | 10.25 | 12.31 |
| Total Liabilities | 8.48 | 10.12 | 16.76 | 17.37 | 14.58 | 12.01 | 11.97 | 15.93 | 19.15 | 22.86 |
| Fixed Assets | 1.38 | 1.11 | 2.1 | 1.84 | 1.55 | 1.15 | 0.37 | 0.22 | 0.26 | 0.28 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Other Assets | 7.06 | 8.97 | 14.62 | 15.49 | 12.99 | 10.82 | 11.56 | 15.67 | 18.85 | 22.54 |
| Total Assets | 8.48 | 10.12 | 16.76 | 17.37 | 14.58 | 12.01 | 11.97 | 15.93 | 19.15 | 22.86 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -1.6 | 0.89 | 3.82 | -3.98 | 0.53 | 1.74 | 1.44 | 1.99 | 0.78 | -0.04 |
| Cash from Investing Activity | 0.62 | 0.15 | -1.07 | 0.08 | 0.09 | 0.24 | 0.68 | 0.06 | -0.12 | 0.06 |
| Cash from Financing Activity | 1.13 | 0.09 | -2.35 | 2.83 | -0.09 | -2 | -3.18 | -1.22 | -0.34 | -0.04 |
| Net Cash Flow | 0.15 | 1.13 | 0.41 | -1.07 | 0.53 | -0.03 | -1.06 | 0.83 | 0.31 | -0.02 |
| Free Cash Flow | -1.46 | 0.93 | 2.67 | -3.99 | 0.52 | 1.91 | 2.06 | 1.98 | 0.57 | -0.11 |
| CFO/OP | 191 | 127 | 260 | -684 | 530 | 187 | 113 | 79 | 97 | 13 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 136.01 | 127.01 | 106.44 | 137.68 | 174.57 | 123.59 | 75.53 | 78.76 | 98.09 | 63.67 |
| Inventory Days | 283.74 | — | — | — | — | — | 280.52 | 186.28 | 468.76 | 279.14 |
| Days Payable | 161.19 | — | — | — | — | — | 171.67 | 79.83 | 382.21 | 173.69 |
| Cash Conversion Cycle | 258.56 | 127.01 | 106.44 | 137.68 | 174.57 | 123.59 | 184.38 | 185.2 | 184.65 | 169.12 |
| Working Capital Days | -4.86 | 0.57 | -30.99 | 25.38 | 58.83 | 57.1 | 74.7 | 67.33 | 102.2 | 61.11 |
| ROCE % | -0.77 | 15.74 | 28.97 | 16.11 | 11.25 | 12.09 | 23.85 | 40.88 | 16.24 | 21.09 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 45.34% | 45.34% | 45.34% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% |
| DIIs | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% |
| Public | 50.09% | 50.09% | 50.09% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% |
| No. of Shareholders | 5514 | 5514 | 5514 | 5513 | 5513 | 5513 | 5513 | 5513 | 5513 | 5513 | 5513 |

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% |
| DIIs | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% |
| Public | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% |
| No. of Shareholders | 5513 | 5513 | 5513 | 5513 | 5513 | 5513 | 5513 | 5513 | 5513 | 5513 | 5513 | 5513 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 5 / 13

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 23.57 | Sell |
| EMA (10) | 23.53 | Sell |
| SMA (20) | 23.78 | Sell |
| EMA (20) | 23.74 | Sell |
| SMA (50) | 24.41 | Sell |
| EMA (50) | 24.3 | Sell |
| SMA (100) | 25.26 | Sell |
| EMA (100) | 25.01 | Sell |
| SMA (200) | 26.6 | Sell |
| EMA (200) | 26.05 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 42.78 | Neutral |
| MACD (12,26,9) | -0.29 | Sell |
| Stochastic (14,3,3) | 50.06 | Neutral |
| ADX (14) | 30.31 | Buy |
| Williams %R (14) | -27.72 | Neutral |
| ATR (14) | 0.6 | Neutral |
| ROC (12) | -1.34 | Sell |
| Stoch RSI (14) | 87.55 | Sell |
| UO (7,14,28) | 59.04 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 5 Nov 2025 - Board meeting on 12 Nov 2025 to approve unaudited Q2/H1 results for period ended 30 Sep 2025. | [Board Meeting Intimation for Notice Of Board Meeting Under Regulation 49 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 5 Nov 2025 - Board meeting on 12 Nov 2025 to approve unaudited Q2/H1 results for period ended 30 Sep 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cf9ac4a8-0d9f-4e9f-baea-4cec0b95f7cc.pdf) |
| 4 Aug - Board meeting on 13 August 2026 to approve audited results for quarter ended 30 June 2026. | [Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015. 4 Aug - Board meeting on 13 August 2026 to approve audited results for quarter ended 30 June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab505e22-ef71-4fda-933b-8555c9012b73.pdf) |
| 30 Apr - Submitted Regulation 40(9) compliance certificate for year ended 31 March 2026. | [With Reference To The Above-Mentioned Subject, The Compliance Certificate Pursuant To Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2026 Given By Mr. Nitesh Kumar Singh, Practicing Company Secretary (M. No.54016 & COP No.20066) Is Enclosed With This Letter. 30 Apr - Submitted Regulation 40(9) compliance certificate for year ended 31 March 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=339bbdec-23f5-429b-92df-0e7a62f46b70.pdf) |
| 30 Apr - Submitted Regulation 40(9) compliance certificate for year ended 31 March 2026. | [With Reference To The Above-Mentioned Subject, The Compliance Certificate Pursuant To Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2026 Given By Mr. Nitesh Kumar Singh, Practicing Company Secretary (M. No.54016 & COP No.20066) Is Enclosed With This Letter. 30 Apr - Submitted Regulation 40(9) compliance certificate for year ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/339bbdec-23f5-429b-92df-0e7a62f46b70.pdf) |
| 30 Apr - Submitted Regulation 40(9) compliance certificate for year ended 31 March 2026. | [With Reference To The Above-Mentioned Subject, The Compliance Certificate Pursuant To Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2026 Given By Mr. Nitesh Kumar Singh, Practicing Company Secretary (M. No.54016 & COP No.20066) Is Enclosed With This Letter. 30 Apr - Submitted Regulation 40(9) compliance certificate for year ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/339bbdec-23f5-429b-92df-0e7a62f46b70.pdf) |
| 30 Apr - Quarterly compliance filed; no change in CS since 1996, and no external RTA appointed. | [Compliance Under Regulation 6(1) And 7(1) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation -2015 For The Quarter Ended 31.03.2026 30 Apr - Quarterly compliance filed; no change in CS since 1996, and no external RTA appointed.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72fa9ea8-7533-48cf-bfc6-5c9bcb1a3926.pdf) |
| 30 Apr - Quarterly compliance filed; no change in CS since 1996, and no external RTA appointed. | [Compliance Under Regulation 6(1) And 7(1) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation -2015 For The Quarter Ended 31.03.2026 30 Apr - Quarterly compliance filed; no change in CS since 1996, and no external RTA appointed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/72fa9ea8-7533-48cf-bfc6-5c9bcb1a3926.pdf) |
| 30 Apr - Quarterly compliance filed; no change in CS since 1996, and no external RTA appointed. | [Compliance Under Regulation 6(1) And 7(1) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation -2015 For The Quarter Ended 31.03.2026 30 Apr - Quarterly compliance filed; no change in CS since 1996, and no external RTA appointed.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/72fa9ea8-7533-48cf-bfc6-5c9bcb1a3926.pdf) |
| 3 Feb - Board meeting on 13 February 2026 to approve unaudited results for quarter ended 31 Dec 2025. | [Board Meeting Intimation for Notice Of Board Meeting 3 Feb - Board meeting on 13 February 2026 to approve unaudited results for quarter ended 31 Dec 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90118e9f-9834-4f1f-8cce-6f5317bb98f0.pdf) |
| 3 Feb - Board meeting on 13 February 2026 to approve unaudited results for quarter ended 31 Dec 2025. | [Board Meeting Intimation for Notice Of Board Meeting 3 Feb - Board meeting on 13 February 2026 to approve unaudited results for quarter ended 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/90118e9f-9834-4f1f-8cce-6f5317bb98f0.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/295552dd-f84f-4423-b94f-7858f26c75d1.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7bcb16c9-8659-4222-aaa4-d43b4179f03c.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b8dcfd87-1e6b-4a08-8d8b-44285eeee390.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/523031/74548523031.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/523031/71340523031.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/523031/66791523031.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/542641/5426410319.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/523031/5230310319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/523031/72942523031.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/523031/5230310317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T20:37:51.682Z.